- Prasugrel or tikagrelor2013 | First Faculty of Medicine
- Prasugrel +12012 | Third Faculty of Medicine
- Anti-platelet treatment: switching from clopidogrel to prasugrel2012 | Publication without faculty affiliation
- Prasugrel - a promising drug in the treatment of atherothrombotic events2009 | First Faculty of Medicine, Third Faculty of Medicine
- Do ticagrelor and prasugrel represent an alternative in the antiplatelet treatment of ischemic stroke? NO2019 | Second Faculty of Medicine
- Prasugrel versus clopidogrel for acute coronary syndromes without revascularization2013 | Faculty of Medicine in Hradec Králové
- Early and Late Benefits of Prasugrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: A TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) Analysis2008 | Third Faculty of Medicine
- Improving outcomes in patients undergoing percutaneous coronary intervention: role of prasugrel2009 | Third Faculty of Medicine
- Effect of Prasugrel Pre-Treatment Strategy in Patients Undergoing Percutaneous Coronary Intervention for NSTEMI The ACCOAST-PCI Study2014 | Third Faculty of Medicine
- Clopidogrel, prasugrel, ticagrelor or vorapaxar in patients with renal impairment: do we have a winner?2015 | Second Faculty of Medicine
- Interval From Initiation of Prasugrel to Coronary Angiography in Patients With Non-ST-Segment Elevation Myocardial Infarction2019 | Third Faculty of Medicine
- 1-Year Outcomes of Patients Undergoing Primary Angioplasty for Myocardial Infarction Treated With Prasugrel Versus Ticagrelor2018 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Clinical outcomes for prasugrel versus clopidogrel in patients with unstable angina or non-ST-elevation myocardial infarction: an analysis from the TRITON-TIMI 38 trial2014 | Third Faculty of Medicine
- An analysis of TRITON-TIMI 38, based on the 12 month recommended length of therapy in the European label for prasugrel2014 | Third Faculty of Medicine
- Antiplatelet therapy in acute coronary syndromes2010 | Publication without faculty affiliation
- Antiplatelet efficacy of P2Y12 inhibitors (prasugrel, ticagrelor, clopidogrel) in patients treated with mild therapeutic hypothermia after cardiac arrest due to acute myocardial infarction2016 | Third Faculty of Medicine, Faculty of Mathematics and Physics
- Among antithrombotic agents, prasugrel, but not ticagrelor, is associated with reduced 30 day mortality in patients with ST-elevated myocardial infarction2015 | Second Faculty of Medicine
- CYP2C19 and CYP3A4 activity and ADP-induced platelet reactivity in prasugrel- or ticagrelor-treated STEMI patients: monocentric study in PRAGUE-18 trial participants2020 | Third Faculty of Medicine
- The clinical importance of antiplatelet resistance and its potential solution2012 | Faculty of Medicine in Pilsen
- Prasugrel Versus Ticagrelor in Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention Multicenter Randomized PRAGUE-18 Study2016 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University
- What is the optimal strategy of prehospital pretreatment of STEMI patients with P2Y12 inhibitors? Experience from Pilsner region in the years 2013-20142016 | Faculty of Medicine in Pilsen
- New antiplatelet drugs in therapy of cardiovascular diseases2009 | First Faculty of Medicine, Third Faculty of Medicine
- What is important for an interventional cardiologist to know about thrombocytes2010 | Publication without faculty affiliation
- Antiplatelet therapy after BVS implantation2017 | First Faculty of Medicine
- The mortality benefit seen with the newer more potent oral P2Y(12) inhibitors prasugrel and ticagrelor over clopidogrel is dependent on the underlying risk: A class effect as suggested by a meta-regression analysis2018 | Third Faculty of Medicine
- Pretreatment with Prasugrel in Non-ST-Segment Elevation Acute Coronary Syndromes2013 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- News In contemporary management of acute coronary syndromes2014 | Faculty of Medicine in Pilsen
- Predictors of bleeding in patients with acute coronary syndromes treated with prasugrel2015 | Third Faculty of Medicine
- The DAPT trial: 12 or 30 months of dual antiplatelet therapy after implantation of drug-eluting stent2016 | First Faculty of Medicine